Loading...

RAPT RAPT THERAPEUTICS INC US FDA Inspections 8-K Filing

RPT

RPT

RAPT THERAPEUTICS INC

(RAPT)

2024 8-K

Show Summary

Show Summary

- Delisting due to Non-Com...

Financial Statements

Financial Results

Investor Presentation

License Agreement

License Agreement

Stock Option Repricing

Financial Results

Earnings Reports

Workforce Reduction

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

FDA Clinical Hold

FDA Clinical Hold on Clinic...

Financial Results Announcement

Clinical Data Announcement

Sales Agreement

Earnings Reports

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Filing of Investor Presenta...

External Links:

RAPT Therapeutics, Inc. announced that the FDA has placed a clinical hold on their Phase 2b trial of zelnecirnon in atopic dermatitis and Phase 2a trial in asthma due to a serious adverse event of liver failure in one patient.

AI Assistant

RAPT THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.